Sorry, you need to enable JavaScript to visit this website.
  1. Home
  2. Our Science
  3. Clinical Trials
  4. Plain Language Study Results Summaries

Plain Language Study Results Summaries

What Are Plain Language Study Results Summaries?

Plain Language Study Results Summaries are descriptions in everyday language of the design and results of clinical studies. These summaries, also called plain language summaries, simple summaries, and trial results summaries, are intended to make clinical results understandable and accessible to patients, healthcare providers, caregivers, researchers, and a general audience.

Please use the search function below to find Plain Language Study Results Summaries for Pfizer-sponsored global clinical trials.

Filter Results

Refine your search results by using the dropdown filters below. Click “reset” to return to the full list of available studies.

A study to Compare the Pharmacokinetics of PF-06882961 in Adult Participants With Varying Degrees of Hepatic Impairment
Category & Conditions: Diabetes and Metabolic Disorders
Study Phase : 1
Medicine: danuglipron (PF-06882961)
Language: English
ViewDownloadPrint
A 16 Week Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Type 2 Diabetes Mellitus
Category & Conditions: Diabetes and Metabolic Disorders
Study Phase : 2
Medicine: danuglipron (PF-06882961)
Language: English
ViewDownloadPrint
A 12-Week Study to Evaluate the Safety, Tolerability and Effects of danuglipron in Adults With Type 2 Diabetes Mellitus Treated With Metformin and Non-Diabetic Adults With Obesity
Category & Conditions: Diabetes and Metabolic Disorders
Study Phase : 2
Medicine: danuglipron (PF-06882961)
Language: English
ViewDownloadPrint
Study Looking at the Interactions Between Levels of Danuglipron and Ervogastat in the Body
Category & Conditions: Diabetes and Metabolic Disorders
Study Phase : 1
Medicine: danuglipron (PF-06882961), PF-06865571
Language: English
ViewDownloadPrint
Study on Use of PF-06687234 in Participants with Active Ulcerative Colitis Already Treated with Infliximab Compared with Infliximab Alone
Category & Conditions: Immune System Diseases and Conditions
Study Phase : 2
Medicine: Dekavil
Language: English
ViewDownloadPrint
Long-Term Use of Crisaborole Ointment Once Daily in Adults, Children, and Infants With Mild-to-Moderate Atopic Dermatitis
Category & Conditions: Skin Diseases and Conditions
Study Phase : 3
Medicine: Eucrisa (crisaborole)
Language: English
ViewDownloadPrint
Study Comparing Use of Crisaborole Ointment With Vehicle Ointment (No Crisaborole) in Children and Adults With Mild to Moderate Atopic Dermatitis
Category & Conditions: Skin Diseases and Conditions
Study Phase : 3
Medicine: Eucrisa (crisaborole)
Language: English
ViewDownloadPrint
Study Comparing Use of Crisaborole Ointment with Vehicle Ointment (No Crisaborole), Corticosteroid Cream, and Calcineurin Inhibitor Cream in Children and Adults with Mild to Moderate Atopic Dermatitis
Category & Conditions: Skin Diseases and Conditions
Study Phase : 3/4
Medicine: Eucrisa (crisaborole)
Language: English
ViewDownloadPrint
A Gene Therapy Study for Hemophilia B
Category & Conditions: Rare Diseases
Study Phase : 2
Medicine: fidanacogene elaparvovec (PF-06838435)
Language: English
ViewDownloadPrint
A Study to Learn About the Efficacy and Safety of Preventive Routine Replacement Treatment with Blood Clotting Factor IX (9) in Men with Hemophilia B
Category & Conditions: Rare Diseases
Study Phase : 3
Medicine: fidanacogene elaparvovec (PF-06838435)
Language: English
ViewDownloadPrint
A gene therapy study to learn about the effects and safety of fidanacogene elaparvovec in men with hemophilia B
Category & Conditions: Immune System Diseases and Conditions
Study Phase : 3
Medicine: fidanacogene elaparvovec (PF-06838435)
Language: English
ViewDownloadPrint
Une étude de thérapie génique visant à en apprendre davantage sur les effets et la sécurité du fidanacogene elaparvovec chez des hommes présentant une hémophilie B
Category & Conditions: Immune System Diseases and Conditions
Study Phase : 3
Medicine: fidanacogene elaparvovec (PF-06838435)
Language: French
ViewDownloadPrint